we have been listening to their false promises for over 7 years.
Unfortunately that seems to be the nature of the beast (I mean bleeding edge biotechs). It's a research project, and to invest early is to gamble that it will work out.
My feeling is that we've had plenty of very positive data on efficacy, other organizations buying in, on the validation of the whole concept of stem cell based therapeutics that there's an excellent chance of an outstanding return on investment here.
In fact if it does work out, I see no reason for anything less than a 10 bagger from here, and potentially much more. A little more patience is required (and yes I know, it's a lot easier for me given my late entry, the result of luck more than any cleverness on my part)